NAD+ guides

Compounded NAD+ is not covered. Why insurers decline, what cash-pay means here, and what to ask your plan.

Read liposomal NAD+ ingredient and formulation claims clearly. Learn what a laboratory study can show and what to ask before comparing it with an injection.

Compare questions about NAD+ nasal spray and prescribed injections, with clear limits on animal studies, IV findings, absorption claims, and product advice.

NAD+ is a coenzyme, not a peptide. Understand the naming confusion, check the actual ingredient, and prepare clear questions about a prescribed product.

NMN is a precursor and NAD+ is a coenzyme. Learn how to read ingredient and route differences, interpret the studied products, and ask clearer questions.

Understand what NAD+ patch claims require, how passive patches differ from assisted devices, and which product questions to bring to a licensed clinician.

Prescription injection against NMN, NR and oral NAD+: regulation, route, evidence, cost units and who decides.

The claimed benefits set against what human trials measured: precursor studies, one infusion pilot, and no controlled trial of the injection.

The four steps from first contact to check-in, who does what at each one, and why your location matters.

The coenzyme, the forms a pharmacy dispenses, and how an injection differs from an oral precursor.

Injectable NAD+ is a compounded drug a pharmacy prepares only on a physician’s order. How telehealth prescribing works.

Injection, nasal spray, capsule, troche and IV infusion: what each is, what has been studied, and why the physician chooses.